Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT06991348

Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole

Led by Carnot Laboratories · Updated on 2025-07-23

128

Participants Needed

2

Research Sites

69 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this clinical trial is to compare which of the two drugs best resolves symptoms in patients diagnosed with erosive and non-erosive gastroesophageal reflux disease, adult males and females. The main question is What is the proportion of patients with resolution of the main symptoms of gastroesophageal reflux disease at four weeks of treatment with pantoprazole vs tegoprazan.

CONDITIONS

Official Title

Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • With endoscopic diagnosis of GERD or NERD within 15 days
  • With positive impedance pHmetry results within 15 days
  • With recurrent heartburn and regurgitation symptoms for 3 months or longer
Not Eligible

You will not qualify if you...

  • Known hypersensitivity to tegoprazan, pantoprazole, or their components
  • Taking atazanavir, nelfinavir, or rilpivirine
  • Having kidney or liver disease, including non-alcoholic hepatitis
  • Having upper gastrointestinal tract bleeding
  • Having gastric or duodenal ulcers within 2 months before screening
  • History of esophageal or gastric surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Gastrologen S.A. de C.V.

Mexico City, Mexico City, Mexico, 01900

Actively Recruiting

2

Saluz Investigación, S.C.

Boca del Río, Veracruz, Mexico, 94299

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole | DecenTrialz